Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorGökbulut, Cengiz
dc.contributor.authorMcKellar, Quintin A.
dc.date.accessioned2019-06-18T06:57:27Z
dc.date.available2019-06-18T06:57:27Z
dc.date.issued2018en_US
dc.identifier.urihttps://10.1016/j.vetpar.2018.08.002
dc.identifier.urihttps://hdl.handle.net/20.500.12462/5465
dc.descriptionGökbulut, Cengiz (Balikesir Author)en_US
dc.description.abstractInternal parasites of horses comprise an intractable problem conferring disease, production and performance losses. Parasitism can rarely be controlled in grazing horses by management alone and anthelmintic drugs have formed the basis of therapy and prophylaxis for the last sixty years. The pharmacology of the anthelmintic drugs available dictate their spectrum of activity and degree of efficacy, their optimal routes of administration and characteristics which prevent some routes of administration, their safety tolerance and potential toxicities and as a consequence of their persistence in the body at effective concentrations their use in epidemiological control programmes. Their use has also resulted in the selection of parasites with genetically controlled characteristics which reduce their susceptibility to treatment, characteristics which are often common to whole chemical classes of anthelmintics. Pharmacological properties also confer compatibility in terms of safety and persistence with other anthelmintic drugs and thus the potential of combinations to treat parasites from different phylogenetic groups such as nematodes, cestodes and trematodes and also the potential by agency of their different molecular mechanisms of action to delay the selection of resistant genes. The major groups of anthelmintics now available, the benzimidazoles (BZD), macrocyclic lactones (MLs) and tetrahydropyrimidines are all highly effective against their targeted parasites (primarily nematodes for BZD's and ML's and cestodes for tetrahydropyrimidines) easily administered orally to horses and are well tolerated with wide margins of safety. Nevertheless, some parasitic stages are inherently less susceptible such as hypobiotic stages of the small strongyles (cyathostomins) and for some such as the adult stages of cyathostomins resistance has developed. Furthermore, for some less common parasites such as the liver fluke unlicensed drugs such as the salicylanilide, closantel have been used. A deep understanding of the pharmacology of anthelmintic drugs is essential to their optimal use in equine speciesen_US
dc.language.isoengen_US
dc.publisherElsevier Scienceen_US
dc.relation.isversionof10.1016/j.vetpar.2018.08.002en_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectAnthelminticsen_US
dc.subjectEquinesen_US
dc.subjectHorseen_US
dc.subjectPonyen_US
dc.subjectDonkeyen_US
dc.subjectBenzimidazolesen_US
dc.subjectMacrocyclic Lactonesen_US
dc.subjectEndectocidesen_US
dc.subjectTetrahydropyrimidinesen_US
dc.subjectResistanceen_US
dc.titleAnthelmintic drugs used in equine speciesen_US
dc.typeotheren_US
dc.relation.journalVeterinary Parasitologyen_US
dc.contributor.departmentTıp Fakültesien_US
dc.identifier.volume261en_US
dc.identifier.startpage27en_US
dc.identifier.endpage52en_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster